Insider transactions

Braden Michael Leonard

CIK 1373603 · last filed 2026-10-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$110.68M
Companies
16
Total Filings
111
Lifetime Open-Market Net
-$12.64M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

BBW price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
156 S. FIRST STREET
ZIONSVILLE, IN 46077
Related Filers
BML Investment Partners, L.P. — 6 joint filings, latest 2010-05-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OM 10%+ Owner 2,764,610 $4.08 $11.28M $870.3K 3 2026-10-05
ACRS 10%+ Owner 13,950,000 $3.79 $52.87M $4.23M 8 2026-04-27
Adverum Biotechnologies, Inc. (ADVM) Delisted 10%+ Owner 2,149,880 $4.36 $9.37M $1.41M 11 2025-12-05
ASTC 10%+ Owner 0 $5.01 $0 -$815.2K 8 2025-10-07
ANTX 10%+ Owner 3,017,432 $3.63 $10.95M -$1.53M 3 2025-06-16
OKUR 447,815 $2.48 $1.11M $0 1 2024-10-09
OnKure Therapeutics, Inc. (RPHM) Delisted 10%+ Owner 447,817 $18.20 $8.15M $1.73M 5 2024-09-26
Talis Biomedical Corp (TLIS) Delisted 10%+ Owner 217,951 $2.84 $619.0K $56.1K 1 2024-08-28
Tectonic Therapeutic, Inc. (AVRO) Delisted 10%+ Owner 405,948 $16.80 $6.82M $971.5K 1 2024-05-15
Enliven Therapeutics, Inc. (IMRA) Delisted 10%+ Owner 499,444 $14.59 $7.29M -$9.40M 9 2023-01-05
RVP 10%+ Owner 1,076,075 $0.58 $625.2K -$2.08M 7 2022-12-29
Metacrine, Inc. (MTCR) Delisted 10%+ Owner 6,760,570 $0.49 $3.35M $936.1K 4 2022-12-21
Satsuma Pharmaceuticals, Inc. (STSA) Delisted 10%+ Owner 6,590,000 $1.10 $7.25M $4.50M 2 2022-11-23
Disc Medicine, Inc. (GMTX) Delisted 10%+ Owner 524,750 $13.50 $7.08M $1.29M 2 2022-10-27
BBW 1,423,043 $23.78 $33.84M -$11.65M 33 2017-10-02
ProPhase Labs, Inc. (PRPH) Delisted 10%+ Owner 62,732 $0.11 $6.9K -$3.16M 7 2017-10-02

Recent Filings · Page 2 of 12

111 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-04-28 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +37,000 $188.9K EDGAR
2025-04-24 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +350,000 $1.05M EDGAR
2025-04-02 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +34,775 $147.1K EDGAR
2025-03-27 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +3,814 $16.8K EDGAR
2025-03-20 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +117,941 $587.6K EDGAR
2025-02-28 Adverum Biotechnologies, Inc. (ADVM) Delisted Buy (P) +336,756 $1.44M EDGAR
2024-10-09 OKUR Other (J) +447,815 $0 EDGAR
2024-09-26 OnKure Therapeutics, Inc. (RPHM) Delisted Buy (P) +98,346 $144.7K EDGAR
2024-09-19 OnKure Therapeutics, Inc. (RPHM) Delisted Buy (P) +56,106 $76.2K EDGAR
2024-09-16 OnKure Therapeutics, Inc. (RPHM) Delisted Buy (P) +358,923 $484.3K EDGAR
Showing 11–20 of 111
Page 2 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.